85 related articles for article (PubMed ID: 4056360)
1. Suramin inhibits duck hepatitis B virus DNA polymerase activity.
Tsiquaye K; Zuckerman A
J Hepatol; 1985; 1(6):663-9. PubMed ID: 4056360
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of the polybasic anion, suramin and acyclovir in Hepadna virus infection.
Tsiquaye KN; Collins P; Zuckerman AJ
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():223-8. PubMed ID: 3793662
[TBL] [Abstract][Full Text] [Related]
3. Screening of antiviral drugs for hepadna virus infection in Pekin ducks: a review.
Zuckerman AJ
J Virol Methods; 1987 Aug; 17(1-2):119-26. PubMed ID: 3312265
[TBL] [Abstract][Full Text] [Related]
4. Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus.
Petcu DJ; Aldrich CE; Coates L; Taylor JM; Mason WS
Virology; 1988 Dec; 167(2):385-92. PubMed ID: 2462306
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human hepatitis B virus DNA polymerase and duck hepatitis B virus DNA polymerase by triphosphates of thymidine analogs and pharmacokinetic properties of the corresponding nucleosides.
Tao PZ; Löfgren B; Lake-Bakaar D; Johansson NG; Datema R; Oberg B
J Med Virol; 1988 Dec; 26(4):353-62. PubMed ID: 3145322
[TBL] [Abstract][Full Text] [Related]
6. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
Sherker AH; Hirota K; Omata M; Okuda K
Gastroenterology; 1986 Oct; 91(4):818-24. PubMed ID: 2943628
[TBL] [Abstract][Full Text] [Related]
7. Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.
Kessler HA; Pottage JC; Trenholme GM; Benson CA; Levin S
AIDS Res; 1986 Feb; 2(1):63-72. PubMed ID: 2424468
[TBL] [Abstract][Full Text] [Related]
8. Suramin treatment for chronic active hepatitis B--toxic and ineffective.
Loke RH; Anderson MG; Coleman JC; Tsiquaye KN; Zuckerman AJ; Murray-Lyon IM
J Med Virol; 1987 Jan; 21(1):97-9. PubMed ID: 3491874
[TBL] [Abstract][Full Text] [Related]
9. Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection.
Hirota K; Sherker AH; Omata M; Yokosuka O; Okuda K
Hepatology; 1987; 7(1):24-8. PubMed ID: 3804202
[TBL] [Abstract][Full Text] [Related]
10. Effects of adenine arabinoside and corticosteroid on replication of duck hepatitis B virus DNA in the liver.
Hirota K; Sherker AH; Omata M; Yokosuka O; Okuda K
Ann Acad Med Singap; 1986 Apr; 15(2):227-32. PubMed ID: 3752897
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
[TBL] [Abstract][Full Text] [Related]
12. Duck hepatitis B virus: DNA polymerase and reverse transcriptase activities of replicative complexes isolated from liver and their inhibition in vitro.
Offensperger WB; Walter E; Offensperger S; Zeschnigk C; Blum HE; Gerok W
Virology; 1988 May; 164(1):48-54. PubMed ID: 2452518
[TBL] [Abstract][Full Text] [Related]
13. Observations on the suramin-mediated inhibition of cellular and viral DNA polymerases.
Basu A; Modak MJ
Biochem Biophys Res Commun; 1985 May; 128(3):1395-402. PubMed ID: 2408617
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction.
Miller RH; Marion PL; Robinson WS
Virology; 1984 Nov; 139(1):64-72. PubMed ID: 6495660
[TBL] [Abstract][Full Text] [Related]
15. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway.
Wu TT; Coates L; Aldrich CE; Summers J; Mason WS
Virology; 1990 Mar; 175(1):255-61. PubMed ID: 2155510
[TBL] [Abstract][Full Text] [Related]
16. Spread of hepatitis B viruses in vitro requires extracellular progeny and may be codetermined by polarized egress.
Funk A; Hohenberg H; Mhamdi M; Will H; Sirma H
J Virol; 2004 Apr; 78(8):3977-83. PubMed ID: 15047813
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo anti-hepatitis B virus activities of the lignan nirtetralin B isolated from Phyllanthus niruri L.
Liu S; Wei W; Li Y; Lin X; Shi K; Cao X; Zhou M
J Ethnopharmacol; 2014 Nov; 157():62-8. PubMed ID: 25260580
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase.
Kassianides C; Hoofnagle JH; Miller RH; Doo E; Ford H; Broder S; Mitsuya H
Gastroenterology; 1989 Nov; 97(5):1275-80. PubMed ID: 2477299
[TBL] [Abstract][Full Text] [Related]
20. Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus.
Tsiquaye KN; Barnard J
J Antimicrob Chemother; 1993 Aug; 32(2):313-23. PubMed ID: 8226434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
